Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Common Equity (2016 - 2025)

InspireMD filings provide 16 years of Common Equity readings, the most recent being $55.2 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 52.97% to $55.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $55.2 million, a 52.97% increase, with the full-year FY2025 number at $55.2 million, up 52.97% from a year prior.
  • Common Equity hit $55.2 million in Q4 2025 for InspireMD, down from $64.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $64.1 million in Q3 2025 to a low of $13.4 million in Q1 2023.
  • Median Common Equity over the past 5 years was $36.6 million (2021), compared with a mean of $36.0 million.
  • Biggest five-year swings in Common Equity: skyrocketed 1164.14% in 2021 and later plummeted 56.71% in 2025.
  • InspireMD's Common Equity stood at $33.5 million in 2021, then tumbled by 48.13% to $17.4 million in 2022, then surged by 127.11% to $39.5 million in 2023, then dropped by 8.65% to $36.1 million in 2024, then skyrocketed by 52.97% to $55.2 million in 2025.
  • The last three reported values for Common Equity were $55.2 million (Q4 2025), $64.1 million (Q3 2025), and $20.2 million (Q2 2025) per Business Quant data.